牙科中的富含血小板纤维素
Journal of applied biomaterials & functional materials
|November 26, 2024
概括
富血小板纤维素 (PRF) 是一种安全的,自主生物材料,在牙科中广泛用于组织再生. 这一审查突出了PRF的重点.
科学领域:
- 生物材料科学 生物材料科学
- 再生医学是一种再生医学.
- 牙科应用 牙科应用
背景情况:
- 富血小板纤维素 (PRF) 是第二代自身血小板缩剂.
- PRF含有生长因子和纤维素支架,用于再生医学.
- 它提供了一个安全和生物相容的选择,与其他缩剂相比,副作用较少.
研究的目的:
- 审查血小板丰富纤维素 (PRF) 作为牙科生物材料的进展情况.
- 突出PRF在各种牙科手术中的有希望的应用.
- 提供关于PRF的准备和分类的见解.
主要方法:
- 在PubMed,Google Scholar,X-mol和 GeenMedical数据库中进行了全面的文献搜索.
- 搜索到2024年10月之前的出版物,没有语言限制.
- 包括随机对照试验,临床试验,病例系列和专注于牙科中PRF的系统审查.
主要成果:
- 在牙周软硬组织再生中,PRF具有广泛的应用.
- 在治疗口腔平坦和脉再生等疾病中有效使用PRF.
- 当PRF应用于特定的牙科疾病时,可以获得良好的结果.
结论:
- 由于其自身的性质和再生潜力,PRF是牙科中一个有价值的生物材料.
- 预计对PRF衍生物的进一步研究将加强其口服应用.
- PRF为诊断和治疗各种口腔疾病提供了有希望的见解.
更多相关视频
06:36PRP as a New Approach to Prevent Infection: Preparation and In vitro Antimicrobial Properties of PRP
Published on: April 9, 2013
21.4K
09:13Turbidimetry on Human Washed Platelets: The Effect of the Pannexin1-inhibitor Brilliant Blue FCF on Collagen-induced Aggregation
Published on: April 6, 2017
11.9K
相关概念视频
Formation of the Platelet Plug
4.5K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
4.5K
Clot Retraction and Fibrinolysis
4.1K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
4.1K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
623
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
623
Introduction to Hemostasis
5.7K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
5.7K
Extrinsic and Intrinsic Pathways of Hemostasis
5.6K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
5.6K
Coagulation
4.8K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
4.8K
